AnaptysBio Inc Stock
Price
Target price
€33.40
€33.40
-0.600%
-0.2
-0.600%
€48.09
22.08.24 / Frankfurt
WKN: A2AJ8C / Symbol: ANAB / Name: AnaptysBio / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
AnaptysBio Inc Stock
The price for the AnaptysBio Inc stock decreased slightly today. Compared to yesterday there is a change of -€0.200 (-0.600%).
With 12 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 48 € shows a positive potential of 43.71% compared to the current price of 33.4 € for AnaptysBio Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for AnaptysBio Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of AnaptysBio Inc in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AnaptysBio Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | -0.600% | 8.442% | -1.765% | 79.570% | 72.165% | 54.630% | - |
| Actinium Pharmaceuticals Inc. | -0.710% | 8.213% | -75.669% | -67.418% | -60.354% | -65.538% | -72.725% |
| Immunic Inc. | 0.870% | 9.723% | -2.094% | -18.998% | -8.462% | -84.248% | -89.560% |
| NanoViricides Inc. | -4.650% | -3.529% | -23.364% | 7.895% | 73.545% | -47.503% | -54.036% |
Comments
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio, Inc. (NASDAQ: ANAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $55.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $55.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
News
Why AnaptysBio Was Such a Healthy Stock This Week
Clinical-stage biotech AnaptysBio (NASDAQ: ANAB) has recently been something of a standout, at least on the stock exchange. According to data compiled by S&P Global Market Intelligence, the
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
Many stocks were wobbly over the past few trading days, but we can't say that about biotech AnaptysBio (NASDAQ: ANAB). The company's shares closed the week almost 8% higher in price, according to